NewsBenzingaDieser Analyst von Outlook Therapeutics beginnt die Bewertung mit einer optimistischen Einschätzung; hier sind die Top 5 Neuaufnahmen für Donnerstag Dieser Analyst von Outlook Therapeutics beginnt die Bewertung mit einer optimistischen Einschätzung; hier sind die Top 5 Neuaufnahmen für Donnerstag Benzinga 2026.11.19 13:31 (GMT+0) Open on Benzinga Other news Truist Securities Maintains Hold on Target, Raises Price Target to $172 Aecom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday JPMorgan Chase Spokesperson Says Bank Has Learned That Third Parties Who Provide Services To The Company Were Target Of A Cyber Attack; Sees No Disruption To Our Services Truist Securities Maintains Buy on Lowe's Companies, Lowers Price Target to $240 Conference call: Walmart Sees Q4 Sales $199.236B-$201.142B vs $200.106B Est Boston Scientific Files Preliminary Prospectus Supplement For Four-Tranche Senior Notes Offering To Fund Penumbra Acquisition; Size Not Disclosed
JPMorgan Chase Spokesperson Says Bank Has Learned That Third Parties Who Provide Services To The Company Were Target Of A Cyber Attack; Sees No Disruption To Our Services
Boston Scientific Files Preliminary Prospectus Supplement For Four-Tranche Senior Notes Offering To Fund Penumbra Acquisition; Size Not Disclosed